Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abilify in children and adolescents with autistic disorder
NCT01617447Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jul 2012
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in Autism Spectrum Disorder (ASD), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Jul 2012; status: completed.
02
Drugs
aripiprazole
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01617447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01617447.